Stemcells (STEM) Posts Mixed Q1 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. SPY
3. CRWV
4. BAC
5. RKLB
6. BLK
7. NOW
8. CAT
9. RXRX
10. MSFT

Go back to Stemcells (STEM) Posts Mixed Q1 Results

StemCells, Inc. Reports First Quarter 2014 Financial Results and Provides Business Update

May 14, 2014 4:00 PM EDT

NEWARK, Calif., May 14, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq: STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, today provided a business update and reported financial results for the first quarter ended March 31, 2014.

"We have made substantial progress in our clinical programs this past quarter," said Martin McGlynn, president and CEO of StemCells, Inc. "We completed enrollment in both our Phase I/II chronic spinal cord injury trial and the first of two cohorts in our Phase I/II geographic... More